Farmacia
Facultad
University of California, San Francisco
San Francisco, Estados UnidosPublicacións en colaboración con investigadores/as de University of California, San Francisco (46)
2022
-
Combination of Mycobacterium tuberculosis RS Ratio and CFU Improves the Ability of Murine Efficacy Experiments to Distinguish between Drug Treatments
Antimicrobial Agents and Chemotherapy, Vol. 66, Núm. 4
-
Emerging Therapeutics, Technologies, and Drug Development Strategies to Address Patient Nonadherence and Improve Tuberculosis Treatment
Annual review of pharmacology and toxicology, Vol. 62, pp. 197-210
-
Modeling the Probability of HIV Infection over Time in High-Risk Seronegative Participants Receiving Placebo in Five Randomized Double-Blind Placebo-Controlled HIV Pre-Exposure Prophylaxis Trials: A Patient-Level Pooled Analysis
Pharmaceutics, Vol. 14, Núm. 9
2021
-
A Mechanistic In Vivo/Ex Vivo Pharmacokinetic-Pharmacodynamic Model of Tenofovir for HIV Prevention
CPT: Pharmacometrics and Systems Pharmacology, Vol. 10, Núm. 3, pp. 179-187
-
Clinical Pharmacokinetics of Oral Sodium Selenite and Dosing Implications in the Treatment of Patients with Metastatic Cancer
Drugs in R and D, Vol. 21, Núm. 2, pp. 169-178
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
Mycobacterium tuberculosis precursor rRNA as a measure of treatment-shortening activity of drugs and regimens
Nature Communications, Vol. 12, Núm. 1
-
Oxypurinol pharmacokinetics and pharmacodynamics in healthy volunteers: Influence of BCRP Q141K polymorphism and patient characteristics
Clinical and Translational Science, Vol. 14, Núm. 4, pp. 1431-1443
2020
-
Mechanistic Multiscale Pharmacokinetic Model for the Anticancer Drug 2’,2’-difluorodeoxycytidine (Gemcitabine) in Pancreatic Cancer
Clinical and Translational Science, Vol. 13, Núm. 3, pp. 608-617
-
Optimizing Hydroxychloroquine Dosing for Patients With COVID-19: An Integrative Modeling Approach for Effective Drug Repurposing
Clinical Pharmacology and Therapeutics, Vol. 108, Núm. 2, pp. 253-263
-
Response to “Quantitative Clinical Pharmacology INPUT to SARS-CoV-2 Therapeutics Should be Based on Robust Data”
Clinical Pharmacology and Therapeutics
2019
-
Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: Combined data from two prospective observational studies
PLoS Medicine, Vol. 16, Núm. 4
-
Translational Framework Predicting Tumour Response in Gemcitabine-Treated Patients with Advanced Pancreatic and Ovarian Cancer from Xenograft Studies
AAPS Journal, Vol. 21, Núm. 2
2018
-
2-hydroxyglutarate-mediated autophagy of the endoplasmic reticulum leads to an unusual downregulation of phospholipid biosynthesis in mutant idh1 gliomas
Cancer Research, Vol. 78, Núm. 9, pp. 2290-2304
-
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene
Neuron, Vol. 97, Núm. 6, pp. 1268-1283.e6
-
Predicting tumour growth and its impact on survival in gemcitabine-treated patients with advanced pancreatic cancer
European Journal of Pharmaceutical Sciences, Vol. 115, pp. 296-303
-
Systematic modeling and design evaluation of unperturbed tumor dynamics in xenografts
Journal of Pharmacology and Experimental Therapeutics, Vol. 366, Núm. 1, pp. 96-104
2016
-
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356
Autophagy
-
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy, Vol. 12, Núm. 1, pp. 1-222
-
Mutant IDH1 expression is associated with down-regulation of monocarboxylate transporters
Oncotarget, Vol. 7, Núm. 23, pp. 34942-34955